Immunovant (IMVT) EBT (2018 - 2026)
Immunovant (IMVT) posted EBT of -$150.7 million for Q1 2026, down 38.15% on a QoQ basis from -$109.1 million in Q4 2025, and down 42.35% year-over-year from -$261.4 million in Q1 2025.
Immunovant (IMVT) EBT (2018 - 2026) Analysis & Trends
Immunovant's EBT history runs 9 years deep, the most recent figure standing at -$150.7 million for Q1 2026.
- Quarterly EBT fell 42.35% year-over-year to -$150.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$505.4 million (down 22.39% YoY) and the FY2026 annual result came in at -$505.4 million, down 22.39% from the prior year.
- EBT was -$150.7 million for Q1 2026 at Immunovant, down from -$109.1 million in the prior quarter.
- Across five years, EBT topped out at -$40.0 million in Q2 2022 and bottomed at -$150.7 million in Q1 2026.
- A 5-year average of -$84.4 million and a median of -$75.1 million in 2024 frame the typical range for EBT.
- Annual changes were most pronounced in 2023 — EBT increased 18.0% — and 2024, when it sank 115.37%.
- Immunovant's EBT stood at -$62.8 million in 2022, then advanced by 18.0% to -$51.5 million in 2023, then sank by 115.37% to -$111.0 million in 2024, then advanced by 1.7% to -$109.1 million in 2025, then slumped by 38.15% to -$150.7 million in 2026.
- Business Quant data shows IMVT's EBT at -$150.7 million in Q1 2026, -$109.1 million in Q4 2025, and -$125.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Immunovant | 7.17 Bn | 7.17 Bn | - | -150.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -150.70 Mn |
| Dec 31, 2025 | -109.08 Mn |
| Sep 30, 2025 | -125.91 Mn |
| Jun 30, 2025 | -119.70 Mn |
| Mar 31, 2025 | -105.87 Mn |
| Dec 31, 2024 | -110.97 Mn |
| Sep 30, 2024 | -109.04 Mn |
| Jun 30, 2024 | -87.07 Mn |
| Mar 31, 2024 | -75.09 Mn |
| Dec 31, 2023 | -51.53 Mn |
| Sep 30, 2023 | -58.21 Mn |
| Jun 30, 2023 | -73.95 Mn |
| Mar 31, 2023 | -60.42 Mn |
| Dec 31, 2022 | -62.84 Mn |
| Sep 30, 2022 | -47.67 Mn |
| Jun 30, 2022 | -40.02 Mn |
| Mar 31, 2022 | -47.18 Mn |
| Dec 31, 2021 | -41.39 Mn |
| Sep 30, 2021 | -37.73 Mn |
| Jun 30, 2021 | -30.51 Mn |